Latest Balance Sheet News

Arafura Rare Earths has officially opened its share purchase plan following ASIC lodgement, while also dispatching notices for a July extraordinary general meeting in Perth.

Elanor Investors Group appoints David McNamara as CEO, signaling a leadership shift following a balance sheet recapitalisation and strategic reset. The Board also sees key transitions with Tony Fehon moving to a non-executive role and Su Kiat Lim stepping down.

Maggie Beer Holdings has received a non-binding indicative offer to sell its Hampers and Gifts Australia business for $10 million, including an $8 million upfront payment and up to $2 million contingent on future performance. The deal excludes its core Maggie Beer Products division and awaits due diligence and shareholder approval.

Helios Energy has raised $1.5 million through a share placement priced at $0.003 per share while extinguishing $100,000 of convertible note debt by issuing shares, bolstering working capital.

Biome Australia has inked a binding deal with Specialty Probiotics Australia to shift its Activated Probiotics manufacturing onshore, aiming to boost gross margins above 65% and streamline working capital within 18 months.

Ardea Resources delays the final report for its Kalgoorlie Nickel Project’s Goongarrie Hub DFS beyond June 2026 while initiating a new scandium scoping study, maintaining strong government backing and consortium funding.

Megaport has landed four major AI infrastructure contracts worth A$459 million, fueling its plan to build a globally-distributed AI inference cloud supported by a new A$350 million GPU Pool. The company is raising A$827 million through a fully underwritten entitlement offer to fund these initiatives and future growth.

Pacific Edge has secured NZ$36.1 million through a combination of a NZ$25.4 million placement and a significantly oversubscribed retail offer, reinforcing its strategic position to expand the Cxbladder cancer diagnostic platform.

Promisia Healthcare reported a 58% jump in underlying EBITDAF to $6.6 million for FY26, driven by improved occupancy and operational upgrades. The company introduced a dividend policy tied to operating free cash flow, signalling confidence in sustained cash generation.

AFC Group Holdings reported a sharp 78% drop in revenue to NZ$161,000 and a net loss of NZ$818,000 for FY2026, but secured shareholder backing and plans to expand its wine portfolio and distribution reach.

ImpediMed has revamped its leadership with two new commercial roles and reported encouraging sales momentum for its SOZO device. The company is advancing clinical trials and expanding its presence in cancer survivorship, weight management, and heart health sectors.

Australian Finance Group (ASX:AFG) has kicked off a $15 million on-market share buyback, aiming to return capital to shareholders while maintaining strategic flexibility amid recent share price softness.